Can a Common Vitamin Slow Alzheimer’s? Rutgers Launches Landmark Trial in New Jersey
the staff of the Ridgewood blog
New Brunswick NJ, New Jersey is on the front lines of a medical breakthrough that could change the way we treat Alzheimer’s disease. Rutgers Robert Wood Johnson Medical School has been selected as one of only 40 elite sites nationwide to test Benfotiamine, a synthetic version of Vitamin B1, to see if it can halt the progression of cognitive decline.
